Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna (MRNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The Enterprise Solutions Hub in the Philippines will support the Asia Pacific region and complements Modernas Enterprise Solutions Hubs in…
Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and Rollins are included in this Analyst Blog....…
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-26...…
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-27...…
Investors focus will likely be on Modernas (MRNA) pipeline, especially its late-stage pipeline candidates, when it reports first-quarter earnings....…
Both of these companies are putting the focus on AI....…
Moderna (MRNA) closed the most recent trading day at $130.07, moving -0.5% from the previous trading session....…
...By Blake Brittain
(Reuters) - Moderna Inc failed to persuade......…
read more...…
Pfizer and Moderna each have lost more than 20% since the start of the year....…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Analyst Evan Wang von Guggenheim Securities:
Evan Wang, Analyst von Guggenheim Securities, leitet die Coverage…
Der Weltgesundheitsmarkt wächst stetig. Innovative biotechnologische Ansätze und die fortschreitende Digitalisierung werden in den kommenden Jahren den Gesundheitsmarkt auf den…
The company may be overly optimistic when it comes to its outlook....…
read more...…
Moderna has already been using AI inside and outside of the lab....…
Stephane Bancel, CEO of Moderna, joins "Mad Money" host Jim Cramer to discuss the company's goals to expand vaccine production…
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-20...…
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-19...…
CAMBRIDGE, MA / ACCESSWIRE / April 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Modernas partnership with IBM comes as the drugmaker navigates its post-pandemic boom driven by its mRNA Covid vaccine. ...…
Modernas CEO said the partnership will allow the company to advance and accelerate its mRNA research and help it build…
Moderna Teams With IBM to Explore AI, Quantum Computing in Vaccine Development...…
Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicinesAgreement with…
Investors have gotten used to Modernas rapid vaccine development....…
In the latest trading session, Moderna (MRNA) closed at $142.82, marking a +0.13% move from the previous day....…
Moderna shares have delivered big for early investors....…
NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration said it has amended the emergency use authorizations or…
The U.S. Food and Drug Administration said it has amended the emergency use authorizations or EUAs of COVID-19 bivalent mRNA…
Moderna Inc. stock outperforms competitors despite losses on the day...…
Tuesdays top analyst upgrades and downgrades included Agilon Health, Boston Scientific, General Motors, JPMorgan Chase, Match, Moderna, Okta, Palo Alto…
...April 18 (Reuters) - The U.S. Food and Drug
Administration on Tuesday......…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna Inc. stock underperforms Monday when compared to competitors...…
Mildly positive results from a phase 2b cancer trial fell short of more hopeful investors expectations....…
Die Aktie des US-Biotechunternehmens Moderna steht zu Wochenbeginn erneut kräftig unter Druck. Rund eine Stunde vor dem US-Handelsende notiert das…
These are the stocks posting the largest moves in midday trading....…
Die US-Aktienmärkte haben sich zum Auftakt der neuen Börsenwoche ohne klare Richtung präsentiert. Während sich die Standardwerte am Montag an…
Modernas mRNA vaccine, when combined with Mercks blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer....…
New data bolster the case for Moderna’s experimental cancer treatment, but the path to turning it into a marketable product…
U.S. stocks traded mixed, with the Dow Jones dropping over 25 points on Monday. Here are some big stocks recording…
Die Daten zum Wirkstoff von Moderna stärken die Zuversicht für einen erfolgreichen Einsatz von mRNA-Technologie gegen Krebs. Doch die Forscher…
Moderna (WKN: A2N9D9), das in Zusammenarbeit mit Merck an Krebsspritzen gegen Hauterkrankungen arbeitet, hat nun die Ergebnisse seiner zweiten klinischen…
This stock may reward those who buy and hold for the long term....…
Merck agrees to buy Prometheus Biosciences for about $10.8 billion, and Charles Schwab reports quarterly earnings on Monday, kicking off…
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in…
In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Daniel Eckert und Nando Sommerfeldt über die Image-Schlappe von Lilium,…